Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Syndi Seinfeld

Neurology with Special Qualifications in Child Neurology Hollywood, FL Doctor of Osteopathy

NPI 1346450384 CMS profile 61215

1150 N 35Th Ave Ste 520, Hollywood, FL 33021

Open in the dashboard

General payments

$51,729

116 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$97,787 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Syndi Seinfeld of Hollywood, FL is reported in the CMS Open Payments database as having received $51,729 across 116 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $97,787 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,186 17
2024 General $1,841 15
2023 General $4,364 12
2022 General $2,814 6
2021 General $1,734 6
2020 General $2,980 2
2019 General $34,810 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Syndi Seinfeld
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Syndi Seinfeld were reported at $3,186. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Syndi Seinfeld Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $34,810 $262 $68–$1,313 $163
2020 $2,980 $188 $46–$1,222 $114
2021 $1,734 $183 $45–$1,356 $132
2022 $2,814 $229 $72–$1,177 $149
2023 $4,364 $269 $93–$1,195 $160
2024 $1,841 $300 $98–$1,428 $164
2025 $3,186 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $24,145 35 payments
  2. Aquestive Therapeutics, Inc. $7,803 5 payments
  3. Mallinckrodt Enterprises LLC $6,722 5 payments
  4. Otter Pharmaceuticals, LLC $5,483 5 payments
  5. BTG International, Inc. $2,546 2 payments
  6. Biocodex, Inc. $1,947 4 payments
  7. UCB, Inc. $967 26 payments
  8. Jazz Pharmaceuticals Inc. $655 10 payments
  9. Upsher-Smith Laboratories LLC $362 6 payments
  10. NeuroPace, Inc. $294 4 payments
  11. Other $803 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $18,853 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,613 9 payments
  3. Food and Beverage $5,658 79 payments
  4. Honoraria $4,500 3 payments
  5. Travel and Lodging $4,089 16 payments
  6. Education $17 1 payment
Products named General payments · program years 2019–2025
  1. VNS Therapy $22,532 30 payments
  2. SYMPAZAN Neurology $5,483 5 payments
  3. SYMPAZAN Neurology $4,854 3 payments
  4. LIBERVANT $2,925 1 payment
  5. DIACOMIT $1,947 4 payments
  6. VNS THERAPY SENTIVA MODEL 1000 GENERATOR Neurology $765 2 payments
  7. Epidiolex $622 11 payments
  8. VNS THERAPY SENTIVA MODEL 1000 GENERATOR Cardiology/Vascular Diseases $598 2 payments
  9. Briviact $314 17 payments
  10. RNS Neurostimulator Kit $294 4 payments
  11. Other $1,543 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record